Massive ICU study aims to slash deadly catheter infections

NCT ID NCT06085690

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a quality improvement program called 'ICU-NO CRBSI' to prevent catheter-related bloodstream infections in intensive care units. Over 8,000 patients across multiple hospitals in China will receive either standard care or an enhanced evidence-based infection prevention plan. The goal is to see if the program reduces infection rates and improves compliance with best practices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
evidence-based intervention plan for preventing CRBSI in ICU patients
What this could lead to
If successful, this could establish a proven method to reduce dangerous bloodstream infections in ICUs, improving patient safety and lowering healthcare costs.
What could go wrong
This is an observational quality improvement study, not a controlled trial, so results may be influenced by other factors. The intervention is behavioral, not a drug, so its impact may vary across hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL LINE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • ZhongShan Hospital Affilicated to Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.